ML20072T116

Updates NRC on Schedule for Initiation of Phase I Patient Trials for Neutron Capture Therapy

ML20072T116
Person / Time
Site:	MIT Nuclear Research Reactor
Issue date:	08/30/1994
From:	Bernard J MASSACHUSETTS INSTITUTE OF TECHNOLOGY, CAMBRIDGE
To:	NRC OFFICE OF INFORMATION RESOURCES MANAGEMENT (IRM)
References
NUDOCS 9409150080
Download: ML20072T116 (1)

Text

m r

p.

~

' S,k l

t NUCLEAR REACTOR LABORATORY AN INTERDEPARTMENTAL CENTER OF N -

MASSACHUSETTS INSTITUTE OF TECHNOLOGY O. K. HARLING 138 Albany Street, Cambridge, Mass. 02139-4296 J. A. BERNARD, JR.

Ddector Telefax No. (617) 253-7300 Director of Reactor Operations Telex No. 921473-MIT-CAM Tel No. (617) 253-4202 30 August 1994

[p-fO U.S. Nuclear Regulatory Commission Washington, D.C. 20555 Attn: Document Control Desk

Subject:

Boron Neutron Capture Therapy Phase I Patient Trials Gentlemen:

We are writing to update NRC on our schedule for the initiation of Phase I patient trials for neutron capture therapy. We have identified a patient and intend to perform the initial trial on 6 September 1994 with subsequent sessions on 9,13, and 16 September 1994. All sessions will be in the afternoon. The patient is now undergoing a boron uptake test. If the results of that test are negative, then the therapy will not be initiated. We will notify you by phone of the uptake test result.

Sincerely, k

• t John A. Bernard, P.D.

Director of Reactor Operations MIT Research Reactor JAB /CRM cc:

USNRC - Project Manager, NRR/PDNP l

USNRC - Region I-Chief, l

Effluents Radiation Protection Section (ERPS)

FRSSB/DRSS no.-

,9 0

@"R882augggg,o 0 0 1

von

.